Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Rituximab 67 Cyclophosphamide 41 fludarabine phosphate 17 Etoposide 17 Doxorubicin 17 Vincristine 16 Prednisone 16 Filgrastim 14 Mycophenolic Acid 13 Cyclosporine 13 Lenalidomide 12 Antilymphocyte Serum 12 Gemcitabine 11 Radiotherapy 10 fludarabine 9 Peripheral Blood Stem Cell Transplantation 9 Methotrexate 9 Whole-Body Irradiation 8 Tacrolimus 8 Melphalan 8 Carboplatin 8 Bortezomib 8 venetoclax 7 Dexamethasone 7 Cord Blood Stem Cell Transplantation 7 Busulfan 7 ibritumomab tiuxetan 6 Ifosfamide 6 Flow Cytometry 6 obinutuzumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lymphoma, Large B-Cell, Diffuse × MK 2206 × Clear all

NCT01466868 2014-07-10

AKTIL

Centre Leon Berard

Phase 2 Terminated

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡